Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELEVATE: Early Everolimus Conversion in Renal Transplant
NCT01114529Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2010
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of everolimus in kidney transplantation, sponsored by Novartis. Started Aug 2010; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01114529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01114529.